🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/02/2019 | 76,84 | 78,02 | 76,84 | 77,57 | +0,83% | 1,53% | 11.588.365 |
| 27/02/2019 | 76,85 | 77,57 | 76,75 | 76,93 | -0,15% | 1,07% | 7.852.978 |
| 26/02/2019 | 76,83 | 77,39 | 76,34 | 77,04 | +0,45% | 1,37% | 8.927.912 |
| 25/02/2019 | 77,16 | 77,28 | 76,33 | 76,70 | -0,48% | 1,24% | 9.741.265 |
| 22/02/2019 | 76,12 | 77,16 | 76,12 | 77,07 | +1,18% | 1,37% | 8.337.469 |
| 21/02/2019 | 75,55 | 76,36 | 75,52 | 76,17 | +0,50% | 1,11% | 7.740.633 |
| 20/02/2019 | 75,38 | 75,90 | 75,20 | 75,79 | +0,24% | 0,92% | 8.993.517 |
| 19/02/2019 | 76,14 | 76,46 | 75,46 | 75,61 | -0,71% | 1,32% | 9.653.547 |
| 15/02/2019 | 76,01 | 76,46 | 75,64 | 76,15 | +1,10% | 1,08% | 10.886.100 |
| 14/02/2019 | 75,51 | 75,91 | 75,09 | 75,32 | -0,10% | 1,09% | 8.577.042 |
| 13/02/2019 | 74,96 | 75,54 | 74,86 | 75,40 | +0,64% | 0,92% | 10.980.106 |
| 12/02/2019 | 73,75 | 75,31 | 73,58 | 74,92 | +2,36% | 2,35% | 13.676.086 |
| 11/02/2019 | 74,24 | 74,27 | 72,72 | 73,20 | -1,04% | 2,10% | 13.803.942 |
| 08/02/2019 | 73,23 | 73,99 | 73,06 | 73,97 | +0,91% | 1,26% | 9.266.940 |
| 07/02/2019 | 73,42 | 73,60 | 72,62 | 73,30 | -0,74% | 1,33% | 9.661.407 |
| 06/02/2019 | 73,32 | 74,16 | 73,12 | 73,85 | +0,31% | 1,42% | 8.375.721 |
| 05/02/2019 | 73,84 | 74,79 | 73,53 | 73,62 | +0,36% | 1,71% | 12.955.690 |
| 04/02/2019 | 72,47 | 73,37 | 72,21 | 73,35 | +0,55% | 1,59% | 11.824.165 |
| 01/02/2019 | 72,49 | 73,94 | 71,88 | 72,95 | +2,71% | 2,84% | 15.941.757 |
| 31/01/2019 | 69,80 | 71,39 | 69,76 | 71,02 | +1,44% | 2,34% | 16.797.658 |
| 30/01/2019 | 70,10 | 70,43 | 69,68 | 70,01 | +0,19% | 1,08% | 13.941.230 |
| 29/01/2019 | 69,56 | 70,31 | 69,31 | 69,88 | +0,43% | 1,43% | 11.966.693 |
| 28/01/2019 | 69,18 | 69,72 | 68,75 | 69,58 | -0,04% | 1,41% | 13.376.672 |
| 25/01/2019 | 70,44 | 70,46 | 68,82 | 69,61 | -0,30% | 2,33% | 14.054.099 |
| 24/01/2019 | 71,72 | 71,72 | 69,06 | 69,82 | -3,01% | 3,70% | 21.986.621 |
| 23/01/2019 | 72,09 | 72,24 | 71,32 | 71,98 | -0,51% | 1,28% | 14.369.233 |
| 22/01/2019 | 72,11 | 72,71 | 71,91 | 72,36 | -0,05% | 1,11% | 10.568.766 |
| 18/01/2019 | 72,65 | 72,83 | 72,01 | 72,40 | +0,36% | 1,13% | 14.980.741 |
| 17/01/2019 | 70,91 | 72,30 | 70,91 | 72,14 | +1,33% | 1,96% | 16.969.321 |
| 16/01/2019 | 71,32 | 72,30 | 71,06 | 71,19 | +0,15% | 1,74% | 15.272.504 |